Data as of Jan 28
| -0.36 / -1.52%|
The 9 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 25.00, with a high estimate of 34.00 and a low estimate of 23.00. The median estimate represents a +7.30% increase from the last price of 23.30.
The current consensus among 9 polled investment analysts is to Buy stock in PharMerica Corp. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.